CN107312872A - Differentiate multiple PCR primer group, kit and the detection method of H5 subtype avian influenza virus and its NA hypotypes simultaneously - Google Patents

Differentiate multiple PCR primer group, kit and the detection method of H5 subtype avian influenza virus and its NA hypotypes simultaneously Download PDF

Info

Publication number
CN107312872A
CN107312872A CN201710479939.4A CN201710479939A CN107312872A CN 107312872 A CN107312872 A CN 107312872A CN 201710479939 A CN201710479939 A CN 201710479939A CN 107312872 A CN107312872 A CN 107312872A
Authority
CN
China
Prior art keywords
influenza virus
primer
avian influenza
genes
band
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710479939.4A
Other languages
Chinese (zh)
Inventor
彭志
仇微红
叶贺佳
魏榕
钟文婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGZHOU SOUTH CHINA BIOLOGICAL MEDICINE CO Ltd
Original Assignee
GUANGZHOU SOUTH CHINA BIOLOGICAL MEDICINE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGZHOU SOUTH CHINA BIOLOGICAL MEDICINE CO Ltd filed Critical GUANGZHOU SOUTH CHINA BIOLOGICAL MEDICINE CO Ltd
Priority to CN201710479939.4A priority Critical patent/CN107312872A/en
Publication of CN107312872A publication Critical patent/CN107312872A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Abstract

The invention discloses multiple PCR primer group, kit and the detection method for differentiating H5 subtype avian influenza virus and its NA hypotypes simultaneously.Parting and detection primer composition such as SEQ ID NO that the present invention is set up for 6 genes of M, H5, N1, N2, N6 and N8 gene of avian influenza virus:Shown in 1~12.Primer composition of the present invention and kit can differentiate H5 subtype avian influenza virus and its NA hypotypes simultaneously, and high specificity, sensitivity is high, cross reaction is small, reproducible, is detected by multiplexed PCR amplification, can be by the judgements of intuitively characteristic bands, to distinguish the H5 avian influenza virus of different NA hypotypes.The present invention can greatly reduce testing cost, and simple to operate, and the used time is brief, the investigation of prevalence virus and prevention and control to H5 subtype avian influenza virus, ensure that the healthy and sustainable development of aviculture is significant.

Description

Differentiate multiple PCR primer group, the examination of H5 subtype avian influenza virus and its NA hypotypes simultaneously Agent box and detection method
Technical field
The invention belongs to field of molecular detection, H5 subtype avian influenza virus is differentiated simultaneously more particularly, to a kind of And its multiple PCR primer group, kit and the detection method of NA hypotypes.
Background technology
Bird flu (Avian Influenza, AI) is a kind of birds acute infection as caused by avian influenza virus (AIV) Disease, meanwhile, the avian influenza virus of some hypotypes can infect the mankind.Avian influenza virus is that minus strand single-stranded RNA virus mesh just glues disease Malicious section's Influenzavirus A influenza virus, its genome is made up of 8 genetic fragments, respectively PB2, PB1, PA, HA, NP, NA, M and NS, it is antigenic different from neuraminidase (NA) according to its glycoprotein hemagglutinin (HA), can be 16 kinds by AIV points HA hypotypes (H1-H16), 9 kinds of NA hypotypes (N1-N9).Bird flu is caused a disease according to the pathogenic highly pathogenic bird flu that is divided into low Property bird flu, part H5 and H7 are highly pathogenic bird flu, can result in the mortality of chicken group, particularly again and again quick-fried in recent years The H5 epidemic situations of hair, the aquaculture to multiple countries and regions brings huge economic loss.In China, H5N1 subtype avian influenzas disease Poison is isolated in Guangdong Province first in 1996, and H5N1 epidemic situations are broken out in subsequent 2003 Qinghai lake, cause substantial amounts of wild bird Death, H5N1 propagate rapidly progressively spread to from Asia Europe and Africa including 56 countries and regions, recent years, H5N2, H5N6, H5N8 subtype avian influenza virus also at home and abroad successive Outbreak in different regions, cause substantial amounts of poultry dead Die and slaughtered.In addition, part H5 subtype avian influenza virus there occurs antigenic variation, the ability propagated across inter-species is obtained direct Infection people simultaneously causes the case of death also to point out H5 hypotypes not only to bring huge injury to aquaculture, while still human world Sanitarian huge potential safety hazard.
The quick detection and diagnostic method for setting up avian influenza virus not only facilitate early detection and symptom management, while Be conducive to the monitoring of bird flu and the deposit of detection technique, the appearance for reply flu outbreak provides the Monitoring Data of early stage simultaneously The effective precautionary measures are taken in time.The traditional detection method of bird flu includes the separation and identification of virus, and separation AIV's is conventional Method has chick embryo culture partition method, HA the and NA hypotypes of virus can be further discriminated between additionally by Serologic detection, due to fowl The numerous and new variant of influenza subtype continuously emerges, although virus purification and the goldstandard that identification is detection virus, but behaviour Make cumbersome, detection cycle is long, and easily influenceed to make testing result inaccurate and timely by factors such as antibody, be unfavorable for examining for disease Break and for the control of epidemic situation;With biotechnology increasingly renewal and develop rapidly, modern molecular biology means gradually by For detecting AIV, such as real-time fluorescence quantitative PCR, ring mediated isothermal amplification method, gene chips and high-flux sequence, this Although class method specificity and sensitiveness are preferably, the requirement for instrument and equipment is higher, popularizes not enough at present.Polymerization PCR (PCR) is simple to operate, and instrument requirements are not high, time-consuming short, while the degree of accuracy is high, also there is good specificity With sensitiveness, as a result more directly perceived, it is easy to judge, Sample storage is convenient, and inspection again is also convenient for, and the same day can complete, and set up multiple PCR can amplify multiple target gene fragments simultaneously and then realize the quick diagnosis of multiple pathogens and reduce inspection cost.
At present, these four NA hypotypes are relatively conventional with N1, N2, N6 and N8 for the popular H5 subtype avian influenza virus of China, And the outburst of the H5 avian influenza of difference NA hypotypes all has the characteristics of morbidity is anxious, propagation is fast, symptom is similar, thus it is only right with clinic Specific NA hypotypes are not can determine that in the observation of the state of an illness, and the inspection in terms of more detection method at present lays particular emphasis on HA Survey, for that can detect H5 HA with the multiple PCR method of its four kinds common NA hypotypes then there is not yet report simultaneously.
The content of the invention
It is an object of the invention to provide differentiate H5 subtype avian influenza virus and its multiple PCR primer of NA hypotypes simultaneously Group, kit and detection method.
The technical solution used in the present invention is:
Differentiate H5 subtype avian influenza virus and its multiple PCR primer composition of NA hypotypes, its nucleotide sequence point simultaneously It is not as follows:
For the primer of avian influenza virus M genes:
MU:5’-TTCTAACCGACGTCGAAAC-3’;
ML:5’-TTAGTCAGAGTTGACARGAT-3’;
For the primer of avian influenza virus H gene:
H5U:5’-ATGAACACTCARTATGAGG-3’;
H5L:5’-GCATTATCCYTAATCTGTAG-3’;
For the primer of avian influenza virus N1 genes:
N1U:5’-TTCGAGTCTGTTGCTTGGT-3’;
N1L:5’-GGAGTATTCCTCATAGTGAT-3’;
For the primer of avian influenza virus N2 genes:
N2U:5’-CAATTGGCTCTGYTTGTCT-3’;
N2L:5’-TGGTYCCCTGYCCAATTGC-3’;
For the primer of avian influenza virus N6 genes:
N6U:5’-TGCAATCAGAATAGGTGAGG-3’;
N6L:5’-TGCTTGTGTGCGTCATCRT-3’;
For the primer of avian influenza virus N8 genes:
N8U:5’-TTGATGCTGTRGCATGGTC-3’;
N8L:5’-CATGCGACTAGTGCATGAAC-3’;
Above-mentioned base R=A/G, Y=C/T.
Differentiate H5 subtype avian influenza virus and its kit of NA hypotypes simultaneously, it is characterised in that:Containing respectively for fowl The primer of M, H5, N1, N2, N6 and N8 gene order design of influenza virus.
As the further preferred of mentioned reagent box, the nucleotide sequence of the primer is as follows:
For the primer of avian influenza virus M genes:
MU:5’-TTCTAACCGACGTCGAAAC-3’;
ML:5’-TTAGTCAGAGTTGACARGAT-3’;
For the primer of avian influenza virus H gene:
H5U:5’-ATGAACACTCARTATGAGG-3’;
H5L:5’-GCATTATCCYTAATCTGTAG-3’;
For the primer of avian influenza virus N1 genes:
N1U:5’-TTCGAGTCTGTTGCTTGGT-3’;
N1L:5’-GGAGTATTCCTCATAGTGAT-3’;
For the primer of avian influenza virus N2 genes:
N2U:5’-CAATTGGCTCTGYTTGTCT-3’;
N2L:5’-TGGTYCCCTGYCCAATTGC-3’;
For the primer of avian influenza virus N6 genes:
N6U:5’-TGCAATCAGAATAGGTGAGG-3’;
N6L:5’-TGCTTGTGTGCGTCATCRT-3’;
For the primer of avian influenza virus N8 genes:
N8U:5’-TTGATGCTGTRGCATGGTC-3’;
N8L:5’-CATGCGACTAGTGCATGAAC-3’;
Above-mentioned base R=A/G, Y=C/T.
As the further preferred of mentioned reagent box, primer pair MU and ML, primer pair H5U and H5L, primer pair N1U and N1L, primer pair N2U and N2L, primer pair N6U and N6L, primer pair N8U and N8L mol ratio are (2~4):(2~4):(1~ 2):(1~2):(2~4):(1~2).
As the further preferred of mentioned reagent box, also containing reaction solution, archaeal dna polymerase, negative control.
As the further preferred of mentioned reagent box, reaction solution contains 10 × PCR buffer, 2.5mM MgCl2、2.5mM DNTP, three's volume ratio is:2:2:2.5.
As the further preferred of mentioned reagent box, archaeal dna polymerase is Ex Taq polymerases.
Differentiate the detection method of H5 subtype avian influenza virus and its NA hypotypes, including following step while non-diseases is diagnosed Suddenly:
(1) measuring samples nucleic acid is extracted;
(2) measuring samples nucleic acid is subjected to reverse transcription, obtains measuring samples cDNA;
(3) measuring samples cDNA is carried out as template using the primer in foregoing Primer composition or aforementioned agents box Multiplexed PCR amplification;
(4) after gel electrophoresis, according to amplified fragments band and size, judged result:
If there is band in, at least band of 158bp, 215bp two then contains H5 subtype avian influenzas disease in sample Poison;
If the band of 158bp, 215bp two, also characteristic bands of 324bp sizes then contain H5N1 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 396bp sizes then contain H5N2 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 635bp sizes then contain H5N6 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 503bp sizes then contain H5N8 in sample;
In addition to case above, it is judged as not containing H5 subtype avian influenza virus.
As the further preferred of above-mentioned detection method, 25 μ L system components of multiplexed PCR amplification are:Testing sample cDNA 1 μ L, 10 × PCR buffer 2 μ L, 2.5mM MgCl2The μ of 2 μ L, 2.5mM dNTP, 2 μ L, Ex Taq polymerase 0.25 L, the final concentration of 20pmol/uL of each primer, 25 μ L are complemented to RNA-free water.
As the further preferred of above-mentioned detection method, the condition of multiplexed PCR amplification is:94 DEG C of 3min, then 94 DEG C 30s, 54~56 DEG C of 30s, 72 DEG C of 1min, 30~35 circulations, 72 DEG C of 5~10min of extension.
The beneficial effects of the invention are as follows:
The parting and detection that the present invention is set up for 6 genes of M, H5, N1, N2, N6 and N8 gene of avian influenza virus are drawn Compositions such as SEQ ID NO:Shown in 1~12.Primer composition of the present invention and kit can differentiate H5 subtype avian influenzas simultaneously Virus and its NA hypotypes, high specificity, sensitivity are high, and cross reaction is small, reproducible, is detected, can led to by multiplexed PCR amplification The judgement of intuitively characteristic bands is crossed, to distinguish the H5 avian influenza virus of different NA hypotypes.The present invention can greatly reduce detection Cost, and it is simple to operate, and the used time is brief, the investigation of prevalence virus and prevention and control to H5 subtype avian influenza virus, ensures aviculture Healthy and sustainable development it is significant.
Brief description of the drawings
Fig. 1:In the agarose gel electrophoresis figure of the multiplex PCR of clinical Simple infection H5 subtype avian influenza virus, figure, swimming lane 1 is H5N1, and swimming lane 2 is H5N2, and swimming lane 3 is H5N6, and swimming lane 4 is H5N8, and swimming lane 5 is Newcastle Disease Virus template, and swimming lane 6 is DEPC water, swimming lane 7 is 100bp Ladder Marker;
Fig. 2:The agarose gel electrophoresis figure of the multiplex PCR of multi-template;In figure, swimming lane 1 and 2 is H5N1 and H5N2 mixing Template reaction band, swimming lane 3 and 4 is H5N1 and H5N6 hybrid template reaction band, and swimming lane 5 and 6 is the mixed of H5N1 and H5N8 Shuttering reacts band, and swimming lane 7 and 8 is H5N2 and H5N6 hybrid template reaction band, and swimming lane 9 and 10 is H5N2's and H5N6 Hybrid template reacts band, and swimming lane 11 and 12 is H5N6 and H5N8 hybrid template reaction band, and swimming lane 13 is 100bp Ladder Marker;
Fig. 3:Single primer amplification 105The sensitivity test result of~1pg/ μ L cDNA templates;The M that is identified in figure, H5, N1, N2, N6, N8 are respectively corresponding single primer amplification result, and each single primer amplification corresponds to 10 respectively from left to right5~1pg/ μ L CDNA templates, Marker be 100bp Ladder Marker;
Fig. 4:Primer composition amplification concentration is 105The sensitivity test result of~1pg/ μ L cDNA templates;In figure, swimming Road M is 100bp Ladder Marker, and swimming lane is respectively 10 from left to right5~1pg/ μ L cDNA templates.
Embodiment
With reference to embodiment and accompanying drawing, the present invention is described in further detail.Reality used in following embodiments Proved recipe method is conventional method unless otherwise specified.Material, reagent used in following embodiments etc., unless otherwise specified, Commercially obtain.
Embodiment 1, while differentiating the design of the multiple PCR primer composition of H5 subtype avian influenza virus and its NA hypotypes
A large amount of corresponding sequences are downloaded in GenBank according to M, H5, N1, N2, N6 and N8 gene of avian influenza virus, to each The sequence of genetic fragment is analyzed and compared, and finds out each genetic fragment with respect to conservative region, designs specific primer, then right Designed primer is analyzed and screened, and multiple PCR primer composition (being shown in Table 1) of the present invention is obtained, by Shanghai Invitrogen is synthesized, PAGE purifying.
Table 1, primer information
Primer information as shown in table 1, annexs base code R=A/G, Y=C/T, according to the poison of actually detected pathogen The different actual amplified production length obtained to detection of strain can be expected on the length of amplified production fluctuation 3bp up and down.
Embodiment 2, while differentiating the kit of H5 subtype avian influenza virus and its NA hypotypes
Differentiate H5 subtype avian influenza virus and its kit of NA hypotypes simultaneously, including such as SEQ ID NO:Shown in 1~12 While differentiate the multiple PCR primer composition of H5 subtype avian influenza virus and its NA hypotypes, reaction solution, Ex Taq polymerases.
Primer pair MU and ML, primer pair H5U and H5L, primer pair N1U and N1L, primer pair in multiple PCR primer composition N2U and N2L, primer pair N6U and N6L, primer pair N8U and N8L molar concentration rate are 2:2:1:1:2:1;Reaction solution contains 10 ×PCR buffer、2.5mM MgCl2, 2.5mM dNTP, three's volume ratio is:2:2:2.5.
Embodiment 3, while differentiating the detection method of H5 subtype avian influenza virus and its NA hypotypes
(1) nucleic acid extraction:Viral nucleic acid is extracted using TRIzol viral nucleic acids extracting method, concretely comprised the following steps:750 μ L's TRIzol and 250 μ L viral sample allantoic fluid are fully mixed, and stand 5min;Add 200 μ L chloroforms and fully mix standing 5min; 4 DEG C of 12000rpm centrifuge 10min, and upper honest and upright and thrifty 450 μ L are sucked into new clean EP manages, and adds 500 μ L isopropanol, stands Abandoned after 20min, 4 DEG C of 12000rpm centrifugations 10min after supernatant, adherent addition 1ML 70% ice ethanol, 12000rpm centrifugations 5min Supernatant is abandoned, 70% ice ethanol of addition is then repeated and washed once again, EP pipes are inverted to the RNA-free water that 25 μ L are added after drying Elution, obtains viral sample nucleic acid.
(2) reverse transcription:Reverse transcription reaction system is carried out with reference to Promega company reverse transcriptase (article No. M1705) specification, The viral sample nucleic acid of acquisition is subjected to reverse transcription according to following reaction system and reaction condition, viral sample cDNA is obtained;Instead Responsive transcription system:μ L, 50mmol/L the Random Primer (9mer) of 5 × Reverse Transcriptase Buffer 8 μ L, the 5U/ μ L MLV of 4 μ L, 40U Ribonuclease Inhibitor of 2mL, dNTP Mixture (10mM/L) 0.5 The μ L of Reverse Transcriptase 1, the μ L of viral nucleic acid 25;42 DEG C of reverse transcription temperature, reacts 1.5h.
(3) multiplexed PCR amplification:It is 25 μ L by multi-PRC reaction cumulative volume by viral sample cDNA and the article of kit Configure, system component is:1 μ L, 10 × PCR buffer of viral sample cDNA 2 μ L, 2.5mM MgCl22 μ L, 2.5mM μ L, the SEQ ID NO of 2 μ L, Ex Taq polymerase of dNTP 0.25:Each primer of primer shown in 1~12 is final concentration of 20pmol/uL, 25 μ L are complemented to RNA-free water;Reaction condition is:94 DEG C of 3min, then 94 DEG C of 30s, 55 DEG C of 30s, 72 DEG C 1min, 30 circulations, 72 DEG C of extension 5min are placed in 4 DEG C.
(4) Ago-Gel of preparation 1.5%, treats that gelling is solid, takes each μ L of amplified production 5 and 16 × loading of μ L Buffer, which is mixed, adds loading hole, 100bp Ladder Marker, 110V, 40min is added at end, in gel imager Observe each amplified fragments;According to amplified production clip size judged result:
If there is band in, at least band of 158bp, 215bp two then contains H5 subtype avian influenzas disease in sample Poison;
If the band of 158bp, 215bp two, also characteristic bands of 324bp sizes then contain H5N1 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 396bp sizes then contain H5N2 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 635bp sizes then contain H5N6 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 503bp sizes then contain H5N8 in sample;
In addition to case above, it is judged as not containing H5 subtype avian influenza virus.
Embodiment 4, specific test
Respectively using the single positive sample of many plants of known viruse nucleic acid as template, including H5N1, H5N2, H5N6, H5N8, Set control be:Newcastle Disease Virus template;Negative control:DEPC water, is carried out multiple using the Primer composition of embodiment 1 PCR is expanded.
When multiple PCR primer composition is detected to single template, as shown in figure 1, template be H5N1, H5N2, H5N6, H5N8 has amplified M, H5 and respective NA three band, wherein M correspondence 158bp, H5 correspondence 215bp, N1 correspondences respectively 324bp, N2 correspondence 396bp, N6 correspondence 635bp, N8 correspondence 503bp band, Newcastle Disease Virus template and DEPC water are equal Without any band.
Respectively using the mixing cDNA samples of a variety of cause of diseases as template, including H5N1 and H5N2 hybrid template, H5N1 with H5N6 hybrid template, H5N1 and H5N8 hybrid template, H5N2 and H5N6 hybrid template, H5N2 and H5N6 hybrid guided mode The hybrid template of plate, H5N6 and H5N8, multiplexed PCR amplification is carried out using the Primer composition of embodiment 1..
When multiple PCR primer composition is detected to hybrid template, as shown in Fig. 2 H5N1, H5N2, H5N6, H5N8 two The hybrid template amplification of two combinations produces 4 bands, and hybrid template is not in interference effect in amplification.
Above result of the test shows:The multiple PCR primer combination single template of analyte detection and hybrid template of the present invention is special Different in nature strong, cross reaction is small between primer, can be flowed the H5 fowl of distinguishing different NA hypotypes by the judgements of intuitively characteristic bands Influenza Virus.
Embodiment 5, sensitivity and replica test
After reverse transcription, cDNA template concentrations are determined using nucleic acid-protein content meter, then cDNA templates are carried out The serial dilution of 10 times of multiple proportions, it is 10 to obtain concentration5~1pg/ μ L cDNA templates, are entered with single primer and Primer composition respectively Performing PCR is expanded, and is tested and be not repeated 3 times the nucleic acid concentration that determines each DNA profiling on the same day, is expanded with template highest extension rate and is in The positive is its PCR susceptibility.
Single primer amplification result is as shown in figure 3, integrate each primer sensitivity, and the minimum nucleic acid concentration that can be detected is about 100pg/uL;
Primer composition amplification as shown in figure 4, for M, H5, N1, N2, N6, N8 gene it is minimum can detect to 100pg/ μ L sample of nucleic acid.
Above result of the test shows:The multiplex PCR list primer and Primer composition of the present invention has 100pg/ μ L detection Sensitivity, and primer combination after interfere it is small, repeatability it is excellent.
Embodiment 6, clinical sample are examined
The detection of avian influenza virus multiplex PCR is carried out to clinical 50 parts of samples, including 36 parts of pathological material of diseases and 14 parts of cotton swabs.
The testing result of table 2, clinical sample
The testing result of clinical sample is as shown in table 2, in 50 clinical samples, 18 parts of negative sample, 32 parts of positive, its In 1 part of H5N1,10 parts of H5N2,20 parts of H5N6,1 part of H5N8.
Above-described embodiment is preferably embodiment, but embodiments of the present invention are not by above-described embodiment of the invention Limitation, other any Spirit Essences without departing from the present invention and the change made under principle, modification, replacement, combine, simplification, Equivalent substitute mode is should be, is included within protection scope of the present invention.
SEQUENCE LISTING
<110>Guangzhou City Huanan Nonda Biology Medicine Co., Ltd
<120>Differentiate multiple PCR primer group, kit and the detection side of H5 subtype avian influenza virus and its NA hypotypes simultaneously
Method
<130>
<160> 12
<170> PatentIn version 3.5
<210> 1
<211> 19
<212> DNA
<213>Artificial sequence
<400> 1
ttctaaccga cgtcgaaac 19
<210> 2
<211> 20
<212> DNA
<213>Artificial sequence
<400> 2
ttagtcagag ttgacargat 20
<210> 3
<211> 19
<212> DNA
<213>Artificial sequence
<400> 3
atgaacactc artatgagg 19
<210> 4
<211> 20
<212> DNA
<213>Artificial sequence
<400> 4
gcattatccy taatctgtag 20
<210> 5
<211> 19
<212> DNA
<213>Artificial sequence
<400> 5
ttcgagtctg ttgcttggt 19
<210> 6
<211> 20
<212> DNA
<213>Artificial sequence
<400> 6
ggagtattcc tcatagtgat 20
<210> 7
<211> 19
<212> DNA
<213>Artificial sequence
<400> 7
caattggctc tgyttgtct 19
<210> 8
<211> 19
<212> DNA
<213>Artificial sequence
<400> 8
tggtyccctg yccaattgc 19
<210> 9
<211> 20
<212> DNA
<213>Artificial sequence
<400> 9
tgcaatcaga ataggtgagg 20
<210> 10
<211> 19
<212> DNA
<213>Artificial sequence
<400> 10
tgcttgtgtg cgtcatcrt 19
<210> 11
<211> 19
<212> DNA
<213>Artificial sequence
<400> 11
ttgatgctgt rgcatggtc 19
<210> 12
<211> 20
<212> DNA
<213>Artificial sequence
<400> 12
catgcgacta gtgcatgaac 20

Claims (10)

1. differentiate H5 subtype avian influenza virus and its multiple PCR primer composition of NA hypotypes simultaneously, its nucleotide sequence difference It is as follows:
For the primer of avian influenza virus M genes:
MU:5’-TTCTAACCGACGTCGAAAC-3’;
ML:5’-TTAGTCAGAGTTGACARGAT-3’;
For the primer of avian influenza virus H5 genes:
H5U:5’-ATGAACACTCARTATGAGG-3’;
H5L:5’-GCATTATCCYTAATCTGTAG-3’;
For the primer of avian influenza virus N1 genes:
N1U:5’-TTCGAGTCTGTTGCTTGGT-3’;
N1L:5’-GGAGTATTCCTCATAGTGAT-3’;
For the primer of avian influenza virus N2 genes:
N2U:5’-CAATTGGCTCTGYTTGTCT-3’;
N2L:5’-TGGTYCCCTGYCCAATTGC-3’;
For the primer of avian influenza virus N6 genes:
N6U:5’-TGCAATCAGAATAGGTGAGG-3’;
N6L:5’-TGCTTGTGTGCGTCATCRT-3’;
For the primer of avian influenza virus N8 genes:
N8U:5’-TTGATGCTGTRGCATGGTC-3’;
N8L:5’-CATGCGACTAGTGCATGAAC-3’;
Above-mentioned base R=A/G, Y=C/T.
2. differentiate H5 subtype avian influenza virus and its kit of NA hypotypes simultaneously, it is characterised in that:Flowed containing fowl is directed to respectively The primer of M, H5, N1, N2, N6 and N8 gene order design of Influenza Virus.
3. kit according to claim 2, it is characterised in that:The nucleotide sequence of the primer is as follows:
For the primer of avian influenza virus M genes:
MU:5’-TTCTAACCGACGTCGAAAC-3’;
ML:5’-TTAGTCAGAGTTGACARGAT-3’;
For the primer of avian influenza virus H gene:
H5U:5’-ATGAACACTCARTATGAGG-3’;
H5L:5’-GCATTATCCYTAATCTGTAG-3’;
For the primer of avian influenza virus N1 genes:
N1U:5’-TTCGAGTCTGTTGCTTGGT-3’;
N1L:5’-GGAGTATTCCTCATAGTGAT-3’;
For the primer of avian influenza virus N2 genes:
N2U:5’-CAATTGGCTCTGYTTGTCT-3’;
N2L:5’-TGGTYCCCTGYCCAATTGC-3’;
For the primer of avian influenza virus N6 genes:
N6U:5’-TGCAATCAGAATAGGTGAGG-3’;
N6L:5’-TGCTTGTGTGCGTCATCRT-3’;
For the primer of avian influenza virus N8 genes:
N8U:5’-TTGATGCTGTRGCATGGTC-3’;
N8L:5’-CATGCGACTAGTGCATGAAC-3’;
Above-mentioned base R=A/G, Y=C/T.
4. kit according to claim 3, it is characterised in that:Primer pair MU and ML, primer pair H5U and H5L, primer pair N1U and N1L, primer pair N2U and N2L, primer pair N6U and N6L, primer pair N8U and N8L mol ratio are (2~4):(2~4): (1~2):(1~2):(2~4):(1~2).
5. kit according to claim 2, it is characterised in that:Also contain reaction solution, archaeal dna polymerase, negative control.
6. kit according to claim 5, it is characterised in that:Reaction solution contains 10 × PCR buffer, 2.5mM MgCl2, 2.5mM dNTP, three's volume ratio is:2:2:2.5.
7. kit according to claim 5, it is characterised in that:Archaeal dna polymerase is Ex Taq polymerases.
8. differentiating the detection method of H5 subtype avian influenza virus and its NA hypotypes while non-diseases is diagnosed, comprise the following steps:
(1) measuring samples nucleic acid is extracted;
(2) measuring samples nucleic acid is subjected to reverse transcription, obtains measuring samples cDNA;
(3) measuring samples cDNA is utilized into any one of the Primer composition or claim 2~7 of claim 1 as template Primer in kit carries out multiplexed PCR amplification;
(4) after gel electrophoresis, according to amplified fragments band and size, judged result:
If there is band in, at least band of 158bp, 215bp two then contains H5 subtype avian influenza virus in sample;
If the band of 158bp, 215bp two, also characteristic bands of 324bp sizes then contain H5N1 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 396bp sizes then contain H5N2 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 635bp sizes then contain H5N6 in sample;
If the band of 158bp, 215bp two, also characteristic bands of 503bp sizes then contain H5N8 in sample;
In addition to case above, it is judged as not containing H5 subtype avian influenza virus.
9. detection method according to claim 8, it is characterised in that:25 μ L system components of multiplexed PCR amplification are:It is to be measured 1 μ L, 10 × PCR buffer of sample cDNA 2 μ L, 2.5mM MgCl22 μ L, 2.5mM dNTP 2 μ L, Ex Taq Polymerase 0.25 μ L, the final concentration of 20pmol/uL of each primer, 25 μ L are complemented to RNA-free water.
10. detection method according to claim 8, it is characterised in that:The condition of multiplexed PCR amplification is:94 DEG C of 3min, so 94 DEG C of 30s, 54~56 DEG C of 30s, 72 DEG C of 1min, 30~35 circulations afterwards, 72 DEG C extend 5~10min.
CN201710479939.4A 2017-06-22 2017-06-22 Differentiate multiple PCR primer group, kit and the detection method of H5 subtype avian influenza virus and its NA hypotypes simultaneously Pending CN107312872A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710479939.4A CN107312872A (en) 2017-06-22 2017-06-22 Differentiate multiple PCR primer group, kit and the detection method of H5 subtype avian influenza virus and its NA hypotypes simultaneously

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710479939.4A CN107312872A (en) 2017-06-22 2017-06-22 Differentiate multiple PCR primer group, kit and the detection method of H5 subtype avian influenza virus and its NA hypotypes simultaneously

Publications (1)

Publication Number Publication Date
CN107312872A true CN107312872A (en) 2017-11-03

Family

ID=60182070

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710479939.4A Pending CN107312872A (en) 2017-06-22 2017-06-22 Differentiate multiple PCR primer group, kit and the detection method of H5 subtype avian influenza virus and its NA hypotypes simultaneously

Country Status (1)

Country Link
CN (1) CN107312872A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107699637A (en) * 2017-11-15 2018-02-16 福建省农业科学院畜牧兽医研究所 The quick real-time fluorescence quantitative PCR primer for distinguishing neuraminidase N6 genotype and its detection method and application
CN108251559A (en) * 2018-01-24 2018-07-06 北京毅新博创生物科技有限公司 Method of mass spectrography detection influenza A virus H5N1 multiple PCR products and products thereof
CN109628643A (en) * 2019-01-11 2019-04-16 中国动物卫生与流行病学中心 A kind of rapid detection method of H5 subtype avian influenza virus

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006132601A1 (en) * 2005-06-10 2006-12-14 Agency For Science, Technology And Research Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1
CN101058833A (en) * 2007-02-08 2007-10-24 中国检验检疫科学研究院动植物检疫研究所 Primer system and method for detecting and analyzing avian influenza virus
CN103074306A (en) * 2013-02-04 2013-05-01 扬州大学 Newcastle disease virus rNDV-H52AH9 and construction method and application thereof
CN105200049A (en) * 2015-10-21 2015-12-30 广西壮族自治区兽医研究所 GeXP rapid detection kit capable of identifying H5 subtype avian influenza virus and four different NA subtypes thereof at the same time
CN105441586A (en) * 2015-11-28 2016-03-30 长沙市疾病预防控制中心 A-type H5N6 subtype avian influenza virus dual-channel real-time fluorescence PCR (polymerase chain reaction) detection kit and detection method
CN106435024A (en) * 2016-09-26 2017-02-22 南京农业大学 Fluorescent quantitative PCR primer, probe, kit and detection method for detecting avian influenza subtype

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006132601A1 (en) * 2005-06-10 2006-12-14 Agency For Science, Technology And Research Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1
CN101058833A (en) * 2007-02-08 2007-10-24 中国检验检疫科学研究院动植物检疫研究所 Primer system and method for detecting and analyzing avian influenza virus
CN103074306A (en) * 2013-02-04 2013-05-01 扬州大学 Newcastle disease virus rNDV-H52AH9 and construction method and application thereof
CN105200049A (en) * 2015-10-21 2015-12-30 广西壮族自治区兽医研究所 GeXP rapid detection kit capable of identifying H5 subtype avian influenza virus and four different NA subtypes thereof at the same time
CN105441586A (en) * 2015-11-28 2016-03-30 长沙市疾病预防控制中心 A-type H5N6 subtype avian influenza virus dual-channel real-time fluorescence PCR (polymerase chain reaction) detection kit and detection method
CN106435024A (en) * 2016-09-26 2017-02-22 南京农业大学 Fluorescent quantitative PCR primer, probe, kit and detection method for detecting avian influenza subtype

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
S.R.FEREIDOUNI等: "Rapid molecular subtyping by reverse transcription polymerase chain reaction of the neuraminidase gene of avian influenza A viruses", 《VETERINARY MICROBIOLOGY》 *
高基民: "《分子诊断学实验指导》", 28 February 2010, 中国医药科技出版社 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107699637A (en) * 2017-11-15 2018-02-16 福建省农业科学院畜牧兽医研究所 The quick real-time fluorescence quantitative PCR primer for distinguishing neuraminidase N6 genotype and its detection method and application
CN108251559A (en) * 2018-01-24 2018-07-06 北京毅新博创生物科技有限公司 Method of mass spectrography detection influenza A virus H5N1 multiple PCR products and products thereof
CN108251559B (en) * 2018-01-24 2021-08-06 北京毅新博创生物科技有限公司 Method for detecting influenza A virus H5N1 multiplex PCR product by mass spectrometry and product thereof
CN109628643A (en) * 2019-01-11 2019-04-16 中国动物卫生与流行病学中心 A kind of rapid detection method of H5 subtype avian influenza virus

Similar Documents

Publication Publication Date Title
CN102899424B (en) GeXP rapid detection kit capable of simultaneously identifying nine pathogens of chicken respiratory tract diseases
CN107937611B (en) Primer probe set for detecting avian influenza virus subtypes H5, H7 and H9
CN105296670B (en) A kind of H1, H3 and H9 type avian influenza virus detection kit and detection method
CN103981286B (en) Differentiate GeXP rapid detection kit and the primer sets thereof of 8 kinds of virus diseases of pigs
CN105200049B (en) Differentiate the GeXP rapid detection kit of H5 subtype avian influenza virus and its four kinds of difference NA hypotypes simultaneously
CN109554507B (en) Detection method of H5 and H7N9 subtype highly pathogenic avian influenza virus
CN107312872A (en) Differentiate multiple PCR primer group, kit and the detection method of H5 subtype avian influenza virus and its NA hypotypes simultaneously
CN105296673A (en) Influenza A virus molecular detection kit and preparation method thereof
CN110551851A (en) CAMP primer group for amplifying ASFV, kit and application
CN102559935A (en) M-gene based fluorescent RT-PCR (Reverse Transcription Polymerase Chain Reaction) detection method of Nipah virus
CN105349707A (en) RT-LAMP (reverse transcriptase loop-mediated isothermal amplification) kit for porcine epidemic diarrhea viruses and applications thereof
CN107488745A (en) A kind of reagent, detection method and application for NDV detection
CN101363063B (en) Primer, probe, kit and method for detecting A, B and H5 subtype influenza virus by triple fluorescent quantitative RT-PCR
CN103740863A (en) RT-LAMP (Reverse Transcription Loop-Mediated Isothermal Amplification) kit for detecting avian influenza virus subtype H7N9
CN104450956A (en) Real-time fluorescence RT-PCR detection kit for H1N1 type A swine influenza virus and application of detection kit
CN102071263B (en) Nested fluorescence reverse transcription-polymerase chain reaction (RT-PCR) detection reagent for avian influenza virus (AIV) H5 subtype and detection kit
CN105316431B (en) Differentiate the quick detection primer groups of GeXP, kit and its application of three kinds of H5 subtype avian influenza virus combination of infection people simultaneously
CN110205405A (en) A kind of kit and primer and probe of detection and identification Seneca Valley virus, foot and mouth disease virus O, A and Asial type
CN101985664B (en) Nucleotide sequence and kit for detecting type-A influenza virus
CN109722492B (en) Method for detecting H5 and H7N9 subtype highly pathogenic avian influenza virus and H9 subtype avian influenza virus
CN103397110A (en) Loop-mediated isothermal amplification method for detecting schmallenberg virus
CN101392299A (en) Equine influenza detection kit and detection method
CN109468416A (en) The RT-LAMP detection primer of specific detection swine influenza virus and its application, detection reagent and method
CN109628643B (en) Rapid detection method for H5 subtype avian influenza virus
CN104278106B (en) Duplex fluorescence quantitative RT-PCR (reverse transcription-polymerase chain reaction) detection kit for duck tembusu virus and egg drop syndrome virus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20171103

RJ01 Rejection of invention patent application after publication